186 related articles for article (PubMed ID: 38097911)
1. Tailoring tumor-recognizable hyaluronic acid-lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells.
Lee CE; Kim S; Park HW; Lee W; Jangid AK; Choi Y; Jeong WJ; Kim K
Nano Converg; 2023 Dec; 10(1):56. PubMed ID: 38097911
[TBL] [Abstract][Full Text] [Related]
2. Optimized Design of Hyaluronic Acid-Lipid Conjugate Biomaterial for Augmenting CD44 Recognition of Surface-Engineered NK Cells.
Park HW; Lee W; Kim S; Jangid AK; Park J; Lee CE; Kim K
Biomacromolecules; 2024 Mar; 25(3):1959-1971. PubMed ID: 38379131
[TBL] [Abstract][Full Text] [Related]
3. Biomaterial-Mediated Exogenous Facile Coating of Natural Killer Cells for Enhancing Anticancer Efficacy toward Hepatocellular Carcinoma.
Jangid AK; Kim S; Kim HJ; Kim K
Bioconjug Chem; 2023 Oct; 34(10):1789-1801. PubMed ID: 37726892
[TBL] [Abstract][Full Text] [Related]
4. Surface Engineering of Natural Killer Cells with CD44-targeting Ligands for Augmented Cancer Immunotherapy.
Kim S; Li S; Jangid AK; Park HW; Lee DJ; Jung HS; Kim K
Small; 2024 Jun; 20(24):e2306738. PubMed ID: 38161257
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting.
Jangid AK; Kim S; Park HW; Kim HJ; Kim K
Biomacromolecules; 2024 Jan; 25(1):222-237. PubMed ID: 38130077
[TBL] [Abstract][Full Text] [Related]
6. Networked Cluster Formation via Trigonal Lipid Modules for Augmented Ex Vivo NK Cell Priming.
Park J; Kim S; Jangid AK; Park HW; Kim K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338836
[TBL] [Abstract][Full Text] [Related]
7. Lipid-mediated ex vivo cell surface engineering for augmented cellular functionalities.
Kim S; Kim K
Biomater Adv; 2022 Sep; 140():213059. PubMed ID: 35961186
[TBL] [Abstract][Full Text] [Related]
8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
9. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Li WM; Xue L; Mayer LD; Bally MB
Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091
[TBL] [Abstract][Full Text] [Related]
10. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy.
Zhong L; Xu L; Liu Y; Li Q; Zhao D; Li Z; Zhang H; Zhang H; Kan Q; Wang Y; Sun J; He Z
Acta Pharm Sin B; 2019 Mar; 9(2):397-409. PubMed ID: 30972285
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
12. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
13. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
14. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
15. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
[TBL] [Abstract][Full Text] [Related]
16. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
Wei X; Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate.
Arpicco S; Bartkowski M; Barge A; Zonari D; Serpe L; Milla P; Dosio F; Stella B; Giordani S
Front Chem; 2020; 8():578008. PubMed ID: 33381490
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.
Parr MJ; Ansell SM; Choi LS; Cullis PR
Biochim Biophys Acta; 1994 Oct; 1195(1):21-30. PubMed ID: 7918562
[TBL] [Abstract][Full Text] [Related]
20. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
